MIAMI, April 22, 2014 /PRNewswire/ -- Sanomedics International Holdings, Inc. (OTCQB: SIMH) has announced that their subsidiary, Thermomedics, Inc, has recently received continuing confirmation of the Caregiver's outstanding performance at this outpatient location where it has been in continuous use for over a year.
Keith Houlihan, Thermomedics Founder and President, commented that "as one of the earliest adapters of this outstanding new technology, Alvernon set the standard for 'hands-on' comparisons of Caregiver with previous methodologies, and the device has exceeded expectations in this environment!"
He added that "this report helps to confirm the growing acceptance for the Caregiver Thermometer's unique combination of accuracy, ease-of-use, reduced cross-contamination, speed, and cost-savings for medical offices and clinics, particularly those with a primary care responsibility for infants, children, and young adults. And remember that no costly probe covers are required for Caregiver to deliver these benefits."
"This 25-examroom clinic exemplifies the high-volume patient environment for which Caregiver is ideally suited", noted Ron Benincasa, Executive VP of Marketing and Sales. "Nurse's survey remarks ranged from 'it saves so much time and it improves patient intake flow patterns' to 'we love the way it keeps germs from being transferred' to 'it's so easy to use and patients really love not being touched' ", he said. "Of course, the accuracy and rugged reliability which make it truly clinical-grade instrument were much appreciated, as well", he noted.
Designed and developed by the team that first invented Infrared Tympanic Thermometry, led by Thermomedics' CTO, Gary O'Hara, the Caregiver is becoming a primary choice of hospitals and clinics across the nation. With the potential for hundreds of millions of temperatures in the U.S. to be taken by this precise medical instrument…easily, cleanly, safely, accurately, and less-expensively, the Company believes that Caregiver will become the premier device for these measurements within a relatively short time!
About Sanomedics International Holdings, Inc.
Sanomedics International Holdings, Inc. (OTCQB: SIMH) is a medical technology holding company that focuses on game changing products, services and ideas - a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. We plan to grow our existing business organically and through strategic acquisitions specifically relating to healthcare technology and services.
Forward Looking Statements
This press release may contain statements which constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties (for example, the risk that the acquisition is not consummated), and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company's periodic filings with the Securities and Exchange Commission should be viewed for a complete understanding of risk and uncertainty.
SOURCE Sanomedics International Holdings, Inc.